Literature DB >> 20152806

Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.

Akifumi Yamashita1, Norihito Kawashita, Ritsuko Kubota-Koketsu, Yuji Inoue, Yohei Watanabe, Madiha S Ibrahim, Shoji Ideno, Mikihiro Yunoki, Yoshinobu Okuno, Tatsuya Takagi, Teruo Yasunaga, Kazuyoshi Ikuta.   

Abstract

The epitope sequences within the hemagglutinin (HA) of influenza A virus H3N2 at amino acid residues 173-181 and 227-239 that forms anti-parallel beta-sheet structure are similarly recognized by human monoclonal antibodies (HuMAbs), B-1 and D-1 that we recently obtained using the peripheral blood lymphocytes from two influenza-vaccinated volunteers. Both HuMAbs showed strong global neutralization of H3N2 strains. Here we show the significant conservation of the beta-sheet region consisting of the above-mentioned two epitope regions in H3N2. In addition, we also identified the corresponding regions with similar structure in other subtypes such as H1N1 and H5N1. These two regions are similarly located underneath the receptor-binding sites of individual subtypes. Analysis of those regions using sequences available from the Influenza Virus Resource at the National Center for Biotechnology Information revealed that compared with those in the known neutralizing epitopes A-E, those sequences were fairly conserved in human H3N2 (n=7955), swine H1N1 (n=360) and swine H3N2 (n=235); and highly conserved in human H1N1 (n=2722), swine-origin pandemic H1N1 (n=1474), human H5N1 (n=319) and avian H5N1 (n=2349). Phylogenetic tree for these regions formed clearly separable clusters for H1N1, H3N2 and H5N1, irrespective of different host origin. These data may suggest a possible significance of those regions for development of alternative vaccine that could induce neutralizing antibodies reactive against wide-range of influenza virus strains. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20152806     DOI: 10.1016/j.bbrc.2010.02.031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

2.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07

3.  Induction of anti-influenza immunity by modified green fluorescent protein (GFP) carrying hemagglutinin-derived epitope structure.

Authors:  Yuji Inoue; Ritsuko Kubota-Koketsu; Akifumi Yamashita; Mitsuhiro Nishimura; Shoji Ideno; Ken-ichiro Ono; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

Review 4.  Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.

Authors:  Shibo Jiang; Lu Lu; Qi Liu; Wei Xu; Lanying Du
Journal:  Emerg Microbes Infect       Date:  2012-08-08       Impact factor: 7.163

5.  The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding.

Authors:  Peter G Mohr; Yi-Mo Deng; Jennifer L McKimm-Breschkin
Journal:  Virol J       Date:  2015-04-22       Impact factor: 4.099

Review 6.  Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.

Authors:  Shibo Jiang; Runming Li; Lanying Du; Shuwen Liu
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

7.  Apoptosis and other immune biomarkers predict influenza vaccine responsiveness.

Authors:  David Furman; Vladimir Jojic; Brian Kidd; Shai Shen-Orr; Jordan Price; Justin Jarrell; Tiffany Tse; Huang Huang; Peder Lund; Holden T Maecker; Paul J Utz; Cornelia L Dekker; Daphne Koller; Mark M Davis
Journal:  Mol Syst Biol       Date:  2013-04-16       Impact factor: 11.429

8.  Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virus.

Authors:  Ilya Dukhovlinov; Ruslan Al-Shekhadat; Ekaterina Fedorova; Ludmila Stepanova; Marina Potapchuk; Irina Repko; Olga Rusova; Anton Orlov; Ludmila Tsybalova; Oleg Kiselev
Journal:  Med Sci Monit Basic Res       Date:  2013-08-23

9.  Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus.

Authors:  Shoji Ideno; Kaoru Sakai; Mikihiro Yunoki; Ritsuko Kubota-Koketsu; Yuji Inoue; Shota Nakamura; Teruo Yasunaga; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  Biologics       Date:  2013-11-05

10.  Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals.

Authors:  Eleonora Molesti; Francesca Ferrara; Giulia Lapini; Emanuele Montomoli; Nigel Temperton
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.